A morpho-molecular prognostic model for hepatocellular carcinoma (Q36089938)

12 August 2017

A morpho-molecular prognostic model for hepatocellular carcinoma (English)

1 reference

12 August 2017

hepatocellular carcinoma

1 reference

S Srivastava

1

1 reference

12 August 2017

K F Wong

2

1 reference

12 August 2017

C W Ong

3

1 reference

12 August 2017

C Y Huak

4

1 reference

12 August 2017

K G Yeoh

5

1 reference

12 August 2017

M Teh

6

1 reference

12 August 2017

J M Luk

7

1 reference

12 August 2017

M Salto-Tellez

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

19 June 2012

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

107

1 reference

12 August 2017

2

1 reference

12 August 2017

334-339

1 reference

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Global cancer statistics in the year 2000.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Time-dependent ROC curves for censored survival data and a diagnostic marker

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Prognosis of hepatocellular carcinoma: the BCLC staging classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394972

Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.

2 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.230

Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.230

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.230

A decade's studies on metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.230

Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2012.230

Long-term outcome of resection of large hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

1 reference

12 December 2020

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER

1 reference

12 December 2020

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.230

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

22713659

1 reference